Total Debt
$40.9M
Net Debt
-$343.3M
Supernus Pharmaceuticals, Inc. currently has $40.9M in total debt. Net debt is -$343.3M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.
Financial Fundamentals
SUPN • Quarterly Data • 5Y View
| Date | Total Debt ($B) | Cash & Inv. ($B) | Net Debt ($B) | Total Assets | Debt/Assets |
|---|---|---|---|---|---|
| 2026-03-31 | 0.04 | 0.38 | -0.34Net Cash | 1.50 | 2.7% |
| 2025-12-31 | 0.04 | 0.31 | -0.27Net Cash | 1.45 | 2.8% |
| 2025-09-30 | 0.04 | 0.28 | -0.24Net Cash | 1.42 | 3.0% |
| 2025-06-30 | 0.03 | 0.52 | -0.49Net Cash | 1.38 | 2.3% |
| 2025-03-31 | 0.03 | 0.46 | -0.43Net Cash | 1.35 | 2.4% |
| 2024-12-31 | 0.03 | 0.45 | -0.42Net Cash | 1.37 | 2.5% |
| 2024-09-30 | 0.04 | 0.40 | -0.37Net Cash | 1.34 | 2.8% |
| 2024-06-30 | 0.04 | 0.35 | -0.31Net Cash | 1.32 | 3.0% |
| 2024-03-31 | 0.04 | 0.30 | -0.26Net Cash | 1.30 | 3.2% |
| 2023-12-31 | 0.04 | 0.25 | -0.21Net Cash | 1.28 | 3.3% |
| 2023-09-30 | 0.04 | 0.20 | -0.16Net Cash | 1.29 | 3.3% |
| 2023-06-30 | 0.04 | 0.15 | -0.11Net Cash | 1.29 | 3.3% |
| 2023-03-31 | 0.52 | 0.23 | 0.30 | 1.79 | 29.3% |
| 2022-12-31 | 0.44 | 0.46 | -0.02Net Cash | 1.70 | 26.1% |
| 2022-09-30 | 0.44 | 0.39 | 0.05 | 1.69 | 26.2% |
| 2022-06-30 | 0.45 | 0.36 | 0.08 | 1.69 | 26.3% |
| 2022-03-31 | 0.45 | 0.31 | 0.13 | 1.64 | 27.2% |
| 2021-12-31 | 0.43 | 0.34 | 0.09 | 1.69 | 25.3% |
| 2021-09-30 | 0.42 | 0.44 | -0.03Net Cash | 1.56 | 26.9% |
| 2021-06-30 | 0.41 | 0.41 | 0.00 | 1.57 | 26.2% |
| 2021-03-31 | 0.42 | 0.39 | 0.03 | 1.51 | 27.7% |
| 2020-12-31 | 0.41 | 0.42 | -0.01Net Cash | 1.50 | 27.5% |
| 2020-09-30 | 0.41 | 0.35 | 0.06 | 1.51 | 27.4% |
| 2020-06-30 | 0.41 | 0.37 | 0.03 | 1.49 | 27.5% |
| 2020-03-31 | 0.38 | 0.40 | -0.02Net Cash | 1.19 | 32.2% |
| 2019-12-31 | 0.38 | 0.35 | 0.03 | 1.16 | 32.6% |
| 2019-09-30 | 0.37 | 0.30 | 0.07 | 1.11 | 33.3% |
| 2019-06-30 | 0.36 | 0.26 | 0.11 | 1.06 | 34.3% |
| 2019-03-31 | 0.36 | 0.29 | 0.07 | 1.03 | 35.2% |
| 2018-12-31 | 0.33 | 0.36 | -0.03Net Cash | 0.98 | 33.7% |
| 2018-09-30 | 0.33 | 0.28 | 0.05 | 0.92 | 35.3% |
| 2018-06-30 | 0.32 | 0.17 | 0.15 | 0.85 | 37.7% |
| 2018-03-31 | 0.32 | 0.49 | -0.17Net Cash | 0.83 | 38.6% |
| 2017-12-31 | 0.03 | 0.14 | -0.11Net Cash | 0.42 | 6.3% |
| 2017-09-30 | 0.03 | 0.11 | -0.09Net Cash | 0.39 | 7.3% |
| 2017-06-30 | 0.00 | 0.09 | -0.09Net Cash | 0.35 | 0.4% |
| 2017-03-31 | 0.00 | 0.09 | -0.08Net Cash | 0.32 | 1.0% |
| 2016-12-31 | 0.00 | 0.09 | -0.09Net Cash | 0.31 | 1.3% |
| 2016-09-30 | 0.01 | 0.08 | -0.07Net Cash | 0.29 | 2.0% |
| 2016-06-30 | 0.01 | 0.06 | -0.05Net Cash | 0.22 | 2.6% |
| 2016-03-31 | 0.01 | 0.05 | -0.04Net Cash | 0.19 | 2.9% |
| 2015-12-31 | 0.01 | 0.06 | -0.06Net Cash | 0.19 | 3.8% |
| 2015-09-30 | 0.01 | 0.06 | -0.05Net Cash | 0.17 | 4.8% |
| 2015-06-30 | 0.01 | 0.07 | -0.06Net Cash | 0.15 | 5.7% |
| 2015-03-31 | 0.01 | 0.06 | -0.05Net Cash | 0.14 | 8.4% |
| 2014-12-31 | 0.03 | 0.07 | -0.05Net Cash | 0.14 | 19.6% |
| 2014-09-30 | 0.03 | 0.07 | -0.05Net Cash | 0.13 | 21.0% |
| 2014-06-30 | 0.03 | 0.05 | -0.02Net Cash | 0.09 | 30.4% |
| 2014-03-31 | 0.03 | 0.06 | -0.03Net Cash | 0.10 | 29.1% |
| 2013-12-31 | 0.03 | 0.08 | -0.05Net Cash | 0.11 | 31.0% |
| 2013-09-30 | 0.06 | 0.09 | -0.03Net Cash | 0.12 | 48.6% |
| 2013-06-30 | 0.06 | 0.10 | -0.04Net Cash | 0.13 | 44.8% |
| 2013-03-31 | 0.02 | 0.07 | -0.05Net Cash | 0.08 | 25.4% |
| 2012-12-31 | 0.02 | 0.09 | -0.07Net Cash | 0.09 | 24.4% |
| 2012-09-30 | 0.03 | 0.06 | -0.04Net Cash | 0.07 | 38.2% |
| 2012-06-30 | 0.03 | 0.08 | -0.05Net Cash | 0.08 | 34.8% |
| 2012-03-31 | 0.03 | 0.04 | -0.01Net Cash | 0.04 | 67.4% |
| 2011-12-31 | 0.03 | 0.05 | -0.02Net Cash | 0.05 | 54.9% |
| 2011-09-30 | 0.09 | 0.02 | 0.07 | 0.03 | 277.1% |
| 2010-12-31 | 0.07 | 0.03 | 0.04 | 0.05 | 159.5% |
| 2010-09-30 | 0.07 | 0.05 | 0.03 | 0.06 | 130.4% |
| 2009-12-31 | 0.07 | 0.07 | 0.01 | 0.08 | 93.9% |